1. A vision for integrated publicly available information on regulated medical products. Issue 6 (9th April 2022) Authors: Roberts, Khyati; Thakkar, Roopal; Aljuburi, Lina; Boyce, Donna; Curtis, Sean; Dudinak, Jennifer; Fitton, Helen; Garner, Carlos; Garvin, Michael; Longman, Susan; Reilly, Edward; Maitland, Jordan; Reisin Miller, Alexis; Pasté, Muriel; Rohrer, Michelle; Taisey, Mark; Van Baelen, Karin; Wegner, Max Journal: Clinical and translational science Issue: Volume 15:Issue 6(2022) Page Start: 1321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry. Issue 9 (20th August 2019) Authors: Loftus, Edward V; Reinisch, Walter; Panaccione, Remo; Berg, Sofie; Alperovich, Gabriela; Bereswill, Mareike; Kalabic, Jasmina; Petersson, Joel; Thakkar, Roopal; Robinson, Anne M; D'Haens, Geert Journal: Inflammatory bowel diseases Issue: Volume 25:Issue 9(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry. Issue 9 (8th February 2019) Authors: Loftus, Edward V; Reinisch, Walter; Panaccione, Remo; Berg, Sofie; Alperovich, Gabriela; Bereswill, Mareike; Kalabic, Jasmina; Petersson, Joel; Thakkar, Roopal; Robinson, Anne M; D'Haens, Geert Journal: Inflammatory bowel diseases Issue: Volume 25:Issue 9(2019) Page Start: 1522 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. Issue 6 (5th January 2011) Authors: Reinisch, Walter; Sandborn, William J; Hommes, Daniel W; D'Haens, Geert; Hanauer, Stephen; Schreiber, Stefan; Panaccione, Remo; Fedorak, Richard N; Tighe, Mary Beth; Huang, Bidan; Kampman, Wendy; Lazar, Andreas; Thakkar, Roopal Journal: Gut Issue: Volume 60:Issue 6(2011) Page Start: 780 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Adalimumab Therapy Achieves Clinical Remission and Response at Week 26 in Chinese Patients With Crohn's Disease: 1874. (October 2015) Authors: Wallace, Kori; Wu, Kai‐Chun; Ran, Zhi Hua; Gao, Xiang; Chen, Minhu; Zhong, Jie; Sheng, Jian‐Qiu; Kamm, Michael; Travis, Simon; Robinson, Anne; Shapiro, Marisa; Li, Yao; Thakkar, Roopal Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. COVID‐19: A Catalyst to Accelerate Global Regulatory Transformation. Issue 6 (29th September 2020) Authors: Stewart, Jerry; Honig, Peter; AlJuburi, Lina; Autor, Deborah; Berger, Susan; Brady, Patrick; Fitton, Helen; Garner, Carlos; Garvin, Michael; Hukkelhoven, Mathias; Kowalski, Robert; Milligan, Sandra; O'Dowd, Liza; Reilly, Edward; Roberts, Khyati; Robertson, Andrew S.; Taisey, Mark; Thakkar, Roopal... Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 6(2021) Page Start: 1390 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Creating E‐Labeling Platforms: An Industry Vision. Issue 4 (19th May 2020) Authors: Roberts, Khyati; Thakkar, Roopal; Autor, Deborah; Bisordi, Fabio; Fitton, Helen; Garner, Carlos; Garvin, Michael; Honig, Peter; Hukkelhoven, Mathias; Kowalski, Robert; Milligan, Sandra; O'Dowd, Liza; Olmstead, Sharon; Reilly, Edward; Robertson, Andrew S; Rohrer, Michelle; Stewart, Jerry; Taisey, ... Journal: Clinical pharmacology & therapeutics Issue: Volume 108:Issue 4(2020) Page Start: 716 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effect of Adalimumab Dose Escalation on Hospitalization Risk in Patients With Moderately to Severely Active Ulcerative Colitis: 1808. (October 2015) Authors: Feagan, Brian; Skup, Martha; Thakkar, Roopal; Lazar, Andreas; Yang, Min; Macaulay, Dendy; Chao, Jingdong; Sandborn, William J. Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and Safety of Dose Escalation to Adalimumab 80 Mg Every Other Week in Japanese Patients With Crohn's Disease Who Lost Response to Maintenance Therapy: 1873. (October 2015) Authors: Wallace, Kori; Motoya, Satoshi; Watanabe, Mamoru; Hibi, Toshifumi; Lazar, Andreas; Robinson, Anne; Nishimura, Yasuko; Ozawa, Morio; Eichner, Samantha; Thakkar, Roopal Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Open: Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow‐up in the PYRAMID Registry. (June 2018) Authors: D'Haens, Geert; Reinisch, Walter; Panaccione, Remo; Satsangi, Jack; Petersson, Joel; Bereswill, Mareike; Arikan, Dilek; Perotti, Eva; Robinson, Anne M; Kalabic, Jasmina; Alperovich, Gabriela; Thakkar, Roopal; Loftus, Edward V Journal: American journal of gastroenterology Issue: Volume 113:Number 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗